Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-874P is a human pseudogene related to the U6 small nuclear RNA family. U6 small nuclear RNA (snRNA) is a core component of the spliceosome, the molecular machinery responsible for pre-mRNA splicing in eukaryotic cells. However, as a pseudogene, RNU6-874P does not produce a functional U6 snRNA molecule and is generally considered nonfunctional in canonical RNA processing. Pseudogenes can sometimes be transcribed and may influence gene expression by acting as competitive endogenous RNAs or giving rise to regulatory small RNAs (such as siRNAs). Nevertheless, there is no evidence that RNU6-874P itself is therapeutically targeted, encodes a functional snRNA, or plays a direct role in disease biology. Context and supporting details: U6 snRNA is crucial for spliceosome activity and pre-mRNA splicing, but only the parental (functional) snRNA gene products are involved in this process. Pseudogenes are DNA sequences similar to functional genes but typically lack the ability to encode proteins or functional RNAs due to mutations or truncations. Some pseudogenes can be transcribed and may play regulatory roles, such as acting as microRNA "sponges" or giving rise to small RNAs with gene-silencing capability in certain contexts, though this is not established for the RNU6-874P locus specifically. Summary: RNU6-874P is a non-coding RNA pseudogene with no validated biological activity, molecular targeting, or known disease relevance. It is not a therapeutic target, nor does it act as a receptor, enzyme, transporter, or functionally active ncRNA. It primarily serves as a genomic remnant of U6 small nuclear RNA genes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 874, pseudogene (RNU6-874P).